|
|
|
|
| LEADER |
01279cam a2200337 a 4500 |
| 001 |
c000396497 |
| 003 |
CARM |
| 005 |
20140307151152.0 |
| 008 |
140307s1995 txua b 001 0 eng d |
| 010 |
|
|
|a 95142292
|
| 019 |
1 |
|
|a 11609703
|5 LACONCORD2021
|
| 020 |
|
|
|a 354058885X (hbk.)
|
| 035 |
|
|
|a (OCoLC)32606188
|5 LACONCORD2021
|
| 040 |
|
|
|a DLC
|b eng
|c DLC
|d DLC
|d LC
|
| 050 |
0 |
0 |
|a QR185.8.A58
|b B55 1995
|
| 082 |
0 |
4 |
|a 616.0793
|2 20
|
| 245 |
0 |
0 |
|a Bispecific antibodies /
|c Michael W. Fanger [and other contributors].
|
| 260 |
|
|
|a Austin, Tex. :
|b R.G. Landes Co.,
|c 1995.
|
| 300 |
|
|
|a 151 p. :
|b ill. (some col.) ;
|c 26 cm.
|
| 490 |
1 |
|
|a Molecular biology intelligence unit
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Antibody-toxin conjugates.
|
| 650 |
|
0 |
|a Antibody-drug conjugates.
|
| 650 |
|
0 |
|a Bispecific antibodies.
|
| 700 |
1 |
|
|a Fanger, Michael W.
|
| 852 |
8 |
|
|b CARM
|p 0601283
|f BK
|
| 852 |
8 |
|
|b SCAN
|h A3:AH19F0
|i C12991
|p 0601283
|f BK
|
| 830 |
|
0 |
|a Molecular biology intelligence unit (Unnumbered)
|
| 999 |
f |
f |
|i cdc51468-7c0e-5b99-91da-847eb0dc8085
|s 31607601-b858-5609-95a9-9148436a445b
|
| 952 |
f |
f |
|p Can circulate
|a CAVAL
|b CAVAL
|c CAVAL
|d CARM 1 Store
|i book
|m 0601283
|
| 952 |
f |
f |
|a CAVAL
|b CAVAL
|c CAVAL
|d Unmapped Location
|e C12991
|f A3:AH19F0
|h Other scheme
|